DARAEX Trademark

Trademark Overview

On Friday, June 20, 2025, a trademark application was filed for DARAEX with the United States Patent and Trademark Office. The USPTO has given the DARAEX trademark a serial number of 99244594. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, December 18, 2025. This trademark is owned by imusyn GmbH & Co KG,. The DARAEX trademark is filed in the Pharmaceutical Products category with the following description:

Immunoassay reagents for medical use, diagnostic agents for medical use, diagnostic reagents for medical use, diagnostic substances for medical use, Reagents for blood grouping for medical purposes
daraex

General Information

Serial Number99244594
Word MarkDARAEX
Filing DateFriday, June 20, 2025
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, December 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesImmunoassay reagents for medical use, diagnostic agents for medical use, diagnostic reagents for medical use, diagnostic substances for medical use, Reagents for blood grouping for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Nameimusyn GmbH & Co KG,
Party Type10 - Original Applicant
Legal Entity Type28 - NOT AVAILABLE
AddressHannover 30625
DE

Trademark Events

Event DateEvent Description
Friday, June 20, 2025NEW APPLICATION ENTERED
Friday, June 20, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 20, 2025APPLICATION FILING RECEIPT MAILED
Friday, November 7, 2025ASSIGNED TO EXAMINER
Wednesday, November 12, 2025SUSPENSION LETTER WRITTEN
Wednesday, November 12, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, November 12, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 17, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, December 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 18, 2025SUSPENSION LETTER WRITTEN
Thursday, December 18, 2025LETTER OF SUSPENSION E-MAILED
Thursday, December 18, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Related Keywords

daraex medical reagents diagnostic grouping purposes blood agents immunoassay substances